CDH1 and neoplasm: Furthermore, a recent report confirmed that not only is E-cadherin expressed on cluster circulating tumor cells (CTCs), which are highly metastatic and predict poor outcome (16, 17), but is even more abundant than EpCAM, the traditional epithelial marker for CTCs (18).